<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03820388</url>
  </required_header>
  <id_info>
    <org_study_id>909765</org_study_id>
    <nct_id>NCT03820388</nct_id>
  </id_info>
  <brief_title>Comparison of Etomidate Plus Propofol, Etomidate Alone on Induction of Anesthesia</brief_title>
  <official_title>Comparison of Etomidate Plus Propofol, Etomidate Alone on Induction of Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of Etomidate plus Propofol vs. Propofol or Etomidate alone during induction of&#xD;
      anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of Etomidate plus Propofol vs. Propofol or Etomidate alone during induction of&#xD;
      anesthesia. The specific aims are testing patient reactions during induction, and in the&#xD;
      post-anesthesia care unit (PACU).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Actual">July 13, 2018</completion_date>
  <primary_completion_date type="Actual">July 13, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients in 3 cohorts will be administered 30 second bolus by manual hand push</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>10 minutes after induction (intraoperative)</time_frame>
    <description>Blood Pressure Fluctuations during Induction; change of blood pressure from baseline from induction to 10 min after induction.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>10 minutes after induction (intraoperative)</time_frame>
    <description>Heart Rate changes during induction (Beats Per min)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain at Injection Site</measure>
    <time_frame>intraoperative</time_frame>
    <description>Pain on injection will be measured using 4 graded scale; 0 = no pain, 1 = verbal complaint of pain, 2 = withdrawal of arm, 3 = both verbal complaint and withdrawal of arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myoclonic Movements</measure>
    <time_frame>intraoperative</time_frame>
    <description>The incidence and degree of myoclonic movements also recorded as follows: 0 = no myoclonic movements, 1 = minor myoclonic movements, 2 = moderate myoclonic movements, 3 = major myoclonic movements.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative Nausea and Vomiting</measure>
    <time_frame>24 hours post-operation</time_frame>
    <description>Presence of post-operative nausea or vomiting (yes/no).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation Depth</measure>
    <time_frame>30 minutes post-induction</time_frame>
    <description>Sedation depth using bispectral index (BIS). BIS scores range from 0-100. A value of 0 indicates no EEG activity, 40-60 indicates an appropriate level of general anesthesia, and 90-100 is typical of a state of wakefulness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Eyelash Reflex Disappear Time</measure>
    <time_frame>Post induction, up to 1 hour</time_frame>
    <description>Time to disappearance of eyelash reflex after induction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intubation Time</measure>
    <time_frame>Up to 2 hours</time_frame>
    <description>Duration of orotracheal intubation.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Propofol Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol 2 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Etomidate Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Etomidate 0.3 mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol plus Etomidate Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol 1 mg/kg plus Etomidate 0.15 mg/kg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol 2mg/kg</intervention_name>
    <description>2 mg/kg</description>
    <arm_group_label>Propofol Group</arm_group_label>
    <other_name>Diprivan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etomidate 0.3 mg/kg</intervention_name>
    <description>0.3 mg/kg</description>
    <arm_group_label>Etomidate Group</arm_group_label>
    <other_name>Amidate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol 1 mg/kg</intervention_name>
    <description>1 mg/kg Propofol</description>
    <arm_group_label>Propofol plus Etomidate Group</arm_group_label>
    <other_name>Diprivan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etomidate 0.15 mg/kg</intervention_name>
    <description>0.15 mg/kg Etomidate</description>
    <arm_group_label>Propofol plus Etomidate Group</arm_group_label>
    <other_name>Amidate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients scheduled for elective non-cardiac surgery&#xD;
&#xD;
          -  ASA physical status of 2 or 3&#xD;
&#xD;
          -  Age equal to or greater than 18 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Adults unable to provide consent&#xD;
&#xD;
          -  Age less than 18 years old&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Difficult airway&#xD;
&#xD;
          -  Morbid Obesity&#xD;
&#xD;
          -  Preoperative sedation use&#xD;
&#xD;
          -  Severe Cardiac, pulmonary and liver disease&#xD;
&#xD;
          -  Hypotension and shock&#xD;
&#xD;
          -  Emergency surgeries&#xD;
&#xD;
          -  Allergy to propofol or etomidate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong Liu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 9, 2018</study_first_submitted>
  <study_first_submitted_qc>January 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2019</study_first_posted>
  <results_first_submitted>December 2, 2020</results_first_submitted>
  <results_first_submitted_qc>February 4, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 23, 2021</results_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Etomidate</keyword>
  <keyword>Propofol</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Etomidate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 15, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/88/NCT03820388/Prot_003.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 26, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/88/NCT03820388/SAP_004.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 26, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/88/NCT03820388/ICF_005.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Propofol Group</title>
          <description>Propofol 2 mg/kg&#xD;
Propofol 2mg/kg: 2 mg/kg</description>
        </group>
        <group group_id="P2">
          <title>Etomidate Group</title>
          <description>Etomidate 0.3 mg/kg&#xD;
Etomidate 0.3 mg/kg: 0.3 mg/kg</description>
        </group>
        <group group_id="P3">
          <title>Propofol Plus Etomidate Group</title>
          <description>Propofol 1 mg/kg plus Etomidate 0.15 mg/kg&#xD;
Propofol 1 mg/kg: 1 mg/kg Propofol&#xD;
Etomidate 0.15 mg/kg: 0.15 mg/kg Etomidate</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Propofol Group</title>
          <description>Propofol 2 mg/kg&#xD;
Propofol 2mg/kg: 2 mg/kg</description>
        </group>
        <group group_id="B2">
          <title>Etomidate Group</title>
          <description>Etomidate 0.3 mg/kg&#xD;
Etomidate 0.3 mg/kg: 0.3 mg/kg</description>
        </group>
        <group group_id="B3">
          <title>Propofol Plus Etomidate Group</title>
          <description>Propofol 1 mg/kg plus Etomidate 0.15 mg/kg&#xD;
Propofol 1 mg/kg: 1 mg/kg Propofol&#xD;
Etomidate 0.15 mg/kg: 0.15 mg/kg Etomidate</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="25"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="25"/>
            <count group_id="B4" value="75"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="25"/>
                    <count group_id="B4" value="75"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.2" spread="8.5"/>
                    <measurement group_id="B2" value="62.5" spread="14.7"/>
                    <measurement group_id="B3" value="61.4" spread="11.6"/>
                    <measurement group_id="B4" value="61.7" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="25"/>
                    <count group_id="B4" value="75"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="25"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="25"/>
                    <count group_id="B4" value="75"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Blood Pressure</title>
        <description>Blood Pressure Fluctuations during Induction; change of blood pressure from baseline from induction to 10 min after induction.</description>
        <time_frame>10 minutes after induction (intraoperative)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>Propofol 2 mg/kg&#xD;
Propofol 2mg/kg: 2 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Etomidate Group</title>
            <description>Etomidate 0.3 mg/kg&#xD;
Etomidate 0.3 mg/kg: 0.3 mg/kg</description>
          </group>
          <group group_id="O3">
            <title>Propofol Plus Etomidate Group</title>
            <description>Propofol 1 mg/kg plus Etomidate 0.15 mg/kg&#xD;
Propofol 1 mg/kg: 1 mg/kg Propofol&#xD;
Etomidate 0.15 mg/kg: 0.15 mg/kg Etomidate</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Pressure</title>
          <description>Blood Pressure Fluctuations during Induction; change of blood pressure from baseline from induction to 10 min after induction.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105" spread="16"/>
                    <measurement group_id="O2" value="122" spread="23"/>
                    <measurement group_id="O3" value="117.88" spread="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Heart Rate</title>
        <description>Heart Rate changes during induction (Beats Per min)</description>
        <time_frame>10 minutes after induction (intraoperative)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>Propofol 2 mg/kg&#xD;
Propofol 2mg/kg: 2 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Etomidate Group</title>
            <description>Etomidate 0.3 mg/kg&#xD;
Etomidate 0.3 mg/kg: 0.3 mg/kg</description>
          </group>
          <group group_id="O3">
            <title>Propofol Plus Etomidate Group</title>
            <description>Propofol 1 mg/kg plus Etomidate 0.15 mg/kg&#xD;
Propofol 1 mg/kg: 1 mg/kg Propofol&#xD;
Etomidate 0.15 mg/kg: 0.15 mg/kg Etomidate</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate</title>
          <description>Heart Rate changes during induction (Beats Per min)</description>
          <units>bpm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77" spread="17"/>
                    <measurement group_id="O2" value="74" spread="12"/>
                    <measurement group_id="O3" value="74" spread="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain at Injection Site</title>
        <description>Pain on injection will be measured using 4 graded scale; 0 = no pain, 1 = verbal complaint of pain, 2 = withdrawal of arm, 3 = both verbal complaint and withdrawal of arm.</description>
        <time_frame>intraoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>Propofol 2 mg/kg&#xD;
Propofol 2mg/kg: 2 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Etomidate Group</title>
            <description>Etomidate 0.3 mg/kg&#xD;
Etomidate 0.3 mg/kg: 0.3 mg/kg</description>
          </group>
          <group group_id="O3">
            <title>Propofol Plus Etomidate Group</title>
            <description>Propofol 1 mg/kg plus Etomidate 0.15 mg/kg&#xD;
Propofol 1 mg/kg: 1 mg/kg Propofol&#xD;
Etomidate 0.15 mg/kg: 0.15 mg/kg Etomidate</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at Injection Site</title>
          <description>Pain on injection will be measured using 4 graded scale; 0 = no pain, 1 = verbal complaint of pain, 2 = withdrawal of arm, 3 = both verbal complaint and withdrawal of arm.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Myoclonic Movements</title>
        <description>The incidence and degree of myoclonic movements also recorded as follows: 0 = no myoclonic movements, 1 = minor myoclonic movements, 2 = moderate myoclonic movements, 3 = major myoclonic movements.</description>
        <time_frame>intraoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>Propofol 2 mg/kg&#xD;
Propofol 2mg/kg: 2 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Etomidate Group</title>
            <description>Etomidate 0.3 mg/kg&#xD;
Etomidate 0.3 mg/kg: 0.3 mg/kg</description>
          </group>
          <group group_id="O3">
            <title>Propofol Plus Etomidate Group</title>
            <description>Propofol 1 mg/kg plus Etomidate 0.15 mg/kg&#xD;
Propofol 1 mg/kg: 1 mg/kg Propofol&#xD;
Etomidate 0.15 mg/kg: 0.15 mg/kg Etomidate</description>
          </group>
        </group_list>
        <measure>
          <title>Myoclonic Movements</title>
          <description>The incidence and degree of myoclonic movements also recorded as follows: 0 = no myoclonic movements, 1 = minor myoclonic movements, 2 = moderate myoclonic movements, 3 = major myoclonic movements.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-operative Nausea and Vomiting</title>
        <description>Presence of post-operative nausea or vomiting (yes/no).</description>
        <time_frame>24 hours post-operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>Propofol 2 mg/kg&#xD;
Propofol 2mg/kg: 2 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Etomidate Group</title>
            <description>Etomidate 0.3 mg/kg&#xD;
Etomidate 0.3 mg/kg: 0.3 mg/kg</description>
          </group>
          <group group_id="O3">
            <title>Propofol Plus Etomidate Group</title>
            <description>Propofol 1 mg/kg plus Etomidate 0.15 mg/kg&#xD;
Propofol 1 mg/kg: 1 mg/kg Propofol&#xD;
Etomidate 0.15 mg/kg: 0.15 mg/kg Etomidate</description>
          </group>
        </group_list>
        <measure>
          <title>Post-operative Nausea and Vomiting</title>
          <description>Presence of post-operative nausea or vomiting (yes/no).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sedation Depth</title>
        <description>Sedation depth using bispectral index (BIS). BIS scores range from 0-100. A value of 0 indicates no EEG activity, 40-60 indicates an appropriate level of general anesthesia, and 90-100 is typical of a state of wakefulness.</description>
        <time_frame>30 minutes post-induction</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>Propofol 2 mg/kg&#xD;
Propofol 2mg/kg: 2 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Etomidate Group</title>
            <description>Etomidate 0.3 mg/kg&#xD;
Etomidate 0.3 mg/kg: 0.3 mg/kg</description>
          </group>
          <group group_id="O3">
            <title>Propofol Plus Etomidate Group</title>
            <description>Propofol 1 mg/kg plus Etomidate 0.15 mg/kg&#xD;
Propofol 1 mg/kg: 1 mg/kg Propofol&#xD;
Etomidate 0.15 mg/kg: 0.15 mg/kg Etomidate</description>
          </group>
        </group_list>
        <measure>
          <title>Sedation Depth</title>
          <description>Sedation depth using bispectral index (BIS). BIS scores range from 0-100. A value of 0 indicates no EEG activity, 40-60 indicates an appropriate level of general anesthesia, and 90-100 is typical of a state of wakefulness.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" spread="8.4"/>
                    <measurement group_id="O2" value="38" spread="11"/>
                    <measurement group_id="O3" value="38" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Eyelash Reflex Disappear Time</title>
        <description>Time to disappearance of eyelash reflex after induction.</description>
        <time_frame>Post induction, up to 1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>Propofol 2 mg/kg&#xD;
Propofol 2mg/kg: 2 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Etomidate Group</title>
            <description>Etomidate 0.3 mg/kg&#xD;
Etomidate 0.3 mg/kg: 0.3 mg/kg</description>
          </group>
          <group group_id="O3">
            <title>Propofol Plus Etomidate Group</title>
            <description>Propofol 1 mg/kg plus Etomidate 0.15 mg/kg&#xD;
Propofol 1 mg/kg: 1 mg/kg Propofol&#xD;
Etomidate 0.15 mg/kg: 0.15 mg/kg Etomidate</description>
          </group>
        </group_list>
        <measure>
          <title>Eyelash Reflex Disappear Time</title>
          <description>Time to disappearance of eyelash reflex after induction.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.9" spread="8.3"/>
                    <measurement group_id="O2" value="34.5" spread="7.5"/>
                    <measurement group_id="O3" value="32.4" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intubation Time</title>
        <description>Duration of orotracheal intubation.</description>
        <time_frame>Up to 2 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Propofol Group</title>
            <description>Propofol 2 mg/kg&#xD;
Propofol 2mg/kg: 2 mg/kg</description>
          </group>
          <group group_id="O2">
            <title>Etomidate Group</title>
            <description>Etomidate 0.3 mg/kg&#xD;
Etomidate 0.3 mg/kg: 0.3 mg/kg</description>
          </group>
          <group group_id="O3">
            <title>Propofol Plus Etomidate Group</title>
            <description>Propofol 1 mg/kg plus Etomidate 0.15 mg/kg&#xD;
Propofol 1 mg/kg: 1 mg/kg Propofol&#xD;
Etomidate 0.15 mg/kg: 0.15 mg/kg Etomidate</description>
          </group>
        </group_list>
        <measure>
          <title>Intubation Time</title>
          <description>Duration of orotracheal intubation.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="25"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" spread="9.6"/>
                    <measurement group_id="O2" value="95" spread="8.9"/>
                    <measurement group_id="O3" value="93" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>duration in-hospital up to 24 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Propofol Group</title>
          <description>Propofol 2 mg/kg&#xD;
Propofol 2mg/kg: 2 mg/kg</description>
        </group>
        <group group_id="E2">
          <title>Etomidate Group</title>
          <description>Etomidate 0.3 mg/kg&#xD;
Etomidate 0.3 mg/kg: 0.3 mg/kg</description>
        </group>
        <group group_id="E3">
          <title>Propofol Plus Etomidate Group</title>
          <description>Propofol 1 mg/kg plus Etomidate 0.15 mg/kg&#xD;
Propofol 1 mg/kg: 1 mg/kg Propofol&#xD;
Etomidate 0.15 mg/kg: 0.15 mg/kg Etomidate</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Hong Liu</name_or_title>
      <organization>University of California Davis</organization>
      <phone>916-734-5031</phone>
      <email>hualiu@ucdavis.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

